Literature DB >> 2200888

Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA.

P J Dillon1, P Nelbock, A Perkins, C A Rosen.   

Abstract

The interaction of the human immunodeficiency virus type 1 (HIV-1) Rev protein with a structured region in env mRNA (the Rev-responsive element [RRE]) mediates the export of structural mRNAs from the nucleus to the cytoplasm. We demonstrated that unlike HIV-1 Rev, which functions with both the HIV-1 and HIV-2 RREs, HIV-2 Rev functions only with the HIV-2 RRE. Rev-RRE binding studies suggested that the lack of nonreciprocal complementation stems from the inability of HIV-2 Rev to interact with HIV-1 RRE RNA. Maintenance of RNA secondary structure, rather than the primary nucleotide sequence, appeared to be the major determinant for interaction of both HIV-1 and HIV-2 Rev with the HIV-2 RRE. Moreover, the binding domain of the HIV-2 RRE recognized by HIV-1 Rev was dissimilar to the binding domain of the HIV-1 RRE, in terms of both secondary structure and primary nucleotide sequence. Our results support the hypothesis that function of HIV Rev proteins and possibly the functionally similar Rex proteins encoded by the human T-cell leukemia viruses (HTLVs) HTLV-I and HTLV-II is controlled by the presence of RNA secondary structure generated within the RRE RNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200888      PMCID: PMC247912     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  A T5 promoter-based transcription-translation system for the analysis of proteins in vitro and in vivo.

Authors:  H Bujard; R Gentz; M Lanzer; D Stueber; M Mueller; I Ibrahimi; M T Haeuptle; B Dobberstein
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

Authors:  J Sodroski; R Patarca; C Rosen; F Wong-Staal; W Haseltine
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

5.  A second post-transcriptional trans-activator gene required for HTLV-III replication.

Authors:  J Sodroski; W C Goh; C Rosen; A Dayton; E Terwilliger; W Haseltine
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

6.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

7.  The art gene product of human immunodeficiency virus is required for replication.

Authors:  E Terwilliger; R Burghoff; R Sia; J Sodroski; W Haseltine; C Rosen
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

8.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Authors:  M B Feinberg; R F Jarrett; A Aldovini; R C Gallo; F Wong-Staal
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

9.  Genome organization and transactivation of the human immunodeficiency virus type 2.

Authors:  M Guyader; M Emerman; P Sonigo; F Clavel; L Montagnier; M Alizon
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

10.  The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.

Authors:  M Emerman; M Guyader; L Montagnier; D Baltimore; M A Muesing
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  30 in total

Review 1.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

2.  Mutational analysis of the human T-cell leukemia virus type I trans-acting rex gene product.

Authors:  L Hofer; I Weichselbraun; S Quick; G K Farrington; E Böhnlein; J Hauber
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2.

Authors:  E D Garrett; B R Cullen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function.

Authors:  Deidra Shuck-Lee; Hua Chang; Emily A Sloan; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

5.  Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.

Authors:  S M Ruben; R Narayanan; J F Klement; C H Chen; C A Rosen
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

Review 6.  Tat and Rev: positive modulators of human immunodeficiency virus gene expression.

Authors:  C A Rosen
Journal:  Gene Expr       Date:  1991-05

7.  Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex.

Authors:  E Böhnlein; J Berger; J Hauber
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element.

Authors:  Michal Legiewicz; Christopher S Badorrek; Kevin B Turner; Daniele Fabris; Tiffany E Hamm; David Rekosh; Marie-Louise Hammarskjöld; Stuart F J Le Grice
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-05       Impact factor: 11.205

9.  Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs.

Authors:  S Schwartz; B K Felber; G N Pavlakis
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

10.  Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.